Inflammatory Bowel Disease linked to elevated psychiatric disorder risk

A nationwide Swedish study examined more than 40,000 patients diagnosed with inflammatory bowel disease (IBD) between 2007 and 2023, comparing them with nearly 180,000 population controls and 26,000 IBD‑free full siblings. The analysis showed that the risk of psychiatric disorders begins to rise two to three years before an IBD diagnosis, peaks within the first six months after diagnosis with a 50% increase, and remains about 19% higher even a decade later. The elevated risk was consistent across Crohn’s disease, ulcerative colitis and unclassified IBD, with the highest absolute risks observed in patients with childhood‑onset IBD and those with a family history of psychiatric conditions.

Prescriptions for antidepressants and anxiolytics increased a year before the IBD diagnosis and stayed elevated for at least five years thereafter. Lead author Jiangwei Sun, PhD, emphasized the need for early psychiatric screening and integrated mental‑health management in IBD care.

The findings suggest that shared genetics or early environmental factors alone do not explain the association, pointing to disease‑related mechanisms such as gut‑brain axis disruption and reduced quality of life as possible contributors.